 | • レポートコード：MRC2012B0148 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、脳腫瘍診断・治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。脳腫瘍診断・治療の種類別市場規模（原発性脳腫瘍、続発性脳腫瘍）、用途別市場規模（病院、医療センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、Shimadzu、Hitachi、Carestream Health、Pfizer、GE Healthcare、Canon Medical Systems、Philips Healthcare、Merck、Siemens Healthineers、 ・地域別グローバル市場分析 2015年-2020年 ・脳腫瘍診断・治療の北米市場（アメリカ、カナダ、メキシコ） ・脳腫瘍診断・治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・脳腫瘍診断・治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・脳腫瘍診断・治療の南米市場（ブラジル、アルゼンチン） ・脳腫瘍診断・治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：原発性脳腫瘍、続発性脳腫瘍 ・用途別分析：病院、医療センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Brain Tumor Diagnosis and Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.6% in the forecast period of 2020 to 2025 and will expected to reach USD 521 million by 2025, from USD 435 million in 2019.
The Brain Tumor Diagnosis and Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Brain Tumor Diagnosis and Treatments market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Brain Tumor Diagnosis and Treatments market has been segmented into:
Primary Brain Tumor
Secondary Brain Tumor
By Application, Brain Tumor Diagnosis and Treatments has been segmented into:
Hospital
Medical center
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Brain Tumor Diagnosis and Treatments market presented in the report. This section sheds light on the sales growth of different regional and country-level Brain Tumor Diagnosis and Treatments markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Brain Tumor Diagnosis and Treatments market.
The report offers in-depth assessment of the growth and other aspects of the Brain Tumor Diagnosis and Treatments market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Brain Tumor Diagnosis and Treatments Market Share Analysis
Brain Tumor Diagnosis and Treatments competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Brain Tumor Diagnosis and Treatments sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Brain Tumor Diagnosis and Treatments sales, revenue and market share for each player covered in this report.
The major players covered in Brain Tumor Diagnosis and Treatments are:
AstraZeneca
Shimadzu
Hitachi
Carestream Health
Pfizer
GE Healthcare
Canon Medical Systems
Philips Healthcare
Merck
Siemens Healthineers
Table of Contents
1 Brain Tumor Diagnosis and Treatments Market Overview
1.1 Product Overview and Scope of Brain Tumor Diagnosis and Treatments
1.2 Classification of Brain Tumor Diagnosis and Treatments by Type
1.2.1 Global Brain Tumor Diagnosis and Treatments Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Brain Tumor Diagnosis and Treatments Revenue Market Share by Type in 2019
1.2.3 Primary Brain Tumor
1.2.4 Secondary Brain Tumor
1.3 Global Brain Tumor Diagnosis and Treatments Market by Application
1.3.1 Overview: Global Brain Tumor Diagnosis and Treatments Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Medical center
1.4 Global Brain Tumor Diagnosis and Treatments Market by Regions
1.4.1 Global Brain Tumor Diagnosis and Treatments Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Brain Tumor Diagnosis and Treatments (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Brain Tumor Diagnosis and Treatments Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Brain Tumor Diagnosis and Treatments Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Brain Tumor Diagnosis and Treatments Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Brain Tumor Diagnosis and Treatments Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Brain Tumor Diagnosis and Treatments Status and Prospect (2015-2025)
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Brain Tumor Diagnosis and Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.2 Shimadzu
2.2.1 Shimadzu Details
2.2.2 Shimadzu Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Shimadzu SWOT Analysis
2.2.4 Shimadzu Product and Services
2.2.5 Shimadzu Brain Tumor Diagnosis and Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hitachi
2.3.1 Hitachi Details
2.3.2 Hitachi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hitachi SWOT Analysis
2.3.4 Hitachi Product and Services
2.3.5 Hitachi Brain Tumor Diagnosis and Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.4 Carestream Health
2.4.1 Carestream Health Details
2.4.2 Carestream Health Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Carestream Health SWOT Analysis
2.4.4 Carestream Health Product and Services
2.4.5 Carestream Health Brain Tumor Diagnosis and Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Brain Tumor Diagnosis and Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.6 GE Healthcare
2.6.1 GE Healthcare Details
2.6.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GE Healthcare SWOT Analysis
2.6.4 GE Healthcare Product and Services
2.6.5 GE Healthcare Brain Tumor Diagnosis and Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.7 Canon Medical Systems
2.7.1 Canon Medical Systems Details
2.7.2 Canon Medical Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Canon Medical Systems SWOT Analysis
2.7.4 Canon Medical Systems Product and Services
2.7.5 Canon Medical Systems Brain Tumor Diagnosis and Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.8 Philips Healthcare
2.8.1 Philips Healthcare Details
2.8.2 Philips Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Philips Healthcare SWOT Analysis
2.8.4 Philips Healthcare Product and Services
2.8.5 Philips Healthcare Brain Tumor Diagnosis and Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck SWOT Analysis
2.9.4 Merck Product and Services
2.9.5 Merck Brain Tumor Diagnosis and Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.10 Siemens Healthineers
2.10.1 Siemens Healthineers Details
2.10.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Siemens Healthineers SWOT Analysis
2.10.4 Siemens Healthineers Product and Services
2.10.5 Siemens Healthineers Brain Tumor Diagnosis and Treatments Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Brain Tumor Diagnosis and Treatments Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Brain Tumor Diagnosis and Treatments Players Market Share
3.2.2 Top 10 Brain Tumor Diagnosis and Treatments Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Brain Tumor Diagnosis and Treatments Revenue and Market Share by Regions
4.2 North America Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
4.3 Europe Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
4.5 South America Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
5 North America Brain Tumor Diagnosis and Treatments Revenue by Countries
5.1 North America Brain Tumor Diagnosis and Treatments Revenue by Countries (2015-2020)
5.2 USA Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
5.3 Canada Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
5.4 Mexico Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
6 Europe Brain Tumor Diagnosis and Treatments Revenue by Countries
6.1 Europe Brain Tumor Diagnosis and Treatments Revenue by Countries (2015-2020)
6.2 Germany Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
6.3 UK Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
6.4 France Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
6.5 Russia Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
6.6 Italy Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Brain Tumor Diagnosis and Treatments Revenue by Countries
7.1 Asia-Pacific Brain Tumor Diagnosis and Treatments Revenue by Countries (2015-2020)
7.2 China Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
7.3 Japan Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
7.4 Korea Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
7.5 India Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
8 South America Brain Tumor Diagnosis and Treatments Revenue by Countries
8.1 South America Brain Tumor Diagnosis and Treatments Revenue by Countries (2015-2020)
8.2 Brazil Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
8.3 Argentina Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Brain Tumor Diagnosis and Treatments by Countries
9.1 Middle East & Africa Brain Tumor Diagnosis and Treatments Revenue by Countries (2015-2020)
9.2 Saudi Arabia Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
9.3 UAE Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
9.4 Egypt Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
9.5 South Africa Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Brain Tumor Diagnosis and Treatments Revenue and Market Share by Type (2015-2020)
10.2 Global Brain Tumor Diagnosis and Treatments Market Forecast by Type (2019-2024)
10.3 Primary Brain Tumor Revenue Growth Rate (2015-2025)
10.4 Secondary Brain Tumor Revenue Growth Rate (2015-2025)
11 Global Brain Tumor Diagnosis and Treatments Market Segment by Application
11.1 Global Brain Tumor Diagnosis and Treatments Revenue Market Share by Application (2015-2020)
11.2 Brain Tumor Diagnosis and Treatments Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Medical center Revenue Growth (2015-2020)
12 Global Brain Tumor Diagnosis and Treatments Market Size Forecast (2021-2025)
12.1 Global Brain Tumor Diagnosis and Treatments Market Size Forecast (2021-2025)
12.2 Global Brain Tumor Diagnosis and Treatments Market Forecast by Regions (2021-2025)
12.3 North America Brain Tumor Diagnosis and Treatments Revenue Market Forecast (2021-2025)
12.4 Europe Brain Tumor Diagnosis and Treatments Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Brain Tumor Diagnosis and Treatments Revenue Market Forecast (2021-2025)
12.6 South America Brain Tumor Diagnosis and Treatments Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Brain Tumor Diagnosis and Treatments Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Brain Tumor Diagnosis and Treatments Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Brain Tumor Diagnosis and Treatments by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Brain Tumor Diagnosis and Treatments Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Brain Tumor Diagnosis and Treatments Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AstraZeneca Corporate Information, Location and Competitors
Table 6. AstraZeneca Brain Tumor Diagnosis and Treatments Major Business
Table 7. AstraZeneca Brain Tumor Diagnosis and Treatments Total Revenue (USD Million) (2017-2018)
Table 8. AstraZeneca SWOT Analysis
Table 9. AstraZeneca Brain Tumor Diagnosis and Treatments Product and Solutions
Table 10. AstraZeneca Brain Tumor Diagnosis and Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Shimadzu Corporate Information, Location and Competitors
Table 12. Shimadzu Brain Tumor Diagnosis and Treatments Major Business
Table 13. Shimadzu Brain Tumor Diagnosis and Treatments Total Revenue (USD Million) (2018-2019)
Table 14. Shimadzu SWOT Analysis
Table 15. Shimadzu Brain Tumor Diagnosis and Treatments Product and Solutions
Table 16. Shimadzu Brain Tumor Diagnosis and Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Hitachi Corporate Information, Location and Competitors
Table 18. Hitachi Brain Tumor Diagnosis and Treatments Major Business
Table 19. Hitachi Brain Tumor Diagnosis and Treatments Total Revenue (USD Million) (2017-2018)
Table 20. Hitachi SWOT Analysis
Table 21. Hitachi Brain Tumor Diagnosis and Treatments Product and Solutions
Table 22. Hitachi Brain Tumor Diagnosis and Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Carestream Health Corporate Information, Location and Competitors
Table 24. Carestream Health Brain Tumor Diagnosis and Treatments Major Business
Table 25. Carestream Health Brain Tumor Diagnosis and Treatments Total Revenue (USD Million) (2017-2018)
Table 26. Carestream Health SWOT Analysis
Table 27. Carestream Health Brain Tumor Diagnosis and Treatments Product and Solutions
Table 28. Carestream Health Brain Tumor Diagnosis and Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer Corporate Information, Location and Competitors
Table 30. Pfizer Brain Tumor Diagnosis and Treatments Major Business
Table 31. Pfizer Brain Tumor Diagnosis and Treatments Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer SWOT Analysis
Table 33. Pfizer Brain Tumor Diagnosis and Treatments Product and Solutions
Table 34. Pfizer Brain Tumor Diagnosis and Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GE Healthcare Corporate Information, Location and Competitors
Table 36. GE Healthcare Brain Tumor Diagnosis and Treatments Major Business
Table 37. GE Healthcare Brain Tumor Diagnosis and Treatments Total Revenue (USD Million) (2017-2018)
Table 38. GE Healthcare SWOT Analysis
Table 39. GE Healthcare Brain Tumor Diagnosis and Treatments Product and Solutions
Table 40. GE Healthcare Brain Tumor Diagnosis and Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Canon Medical Systems Corporate Information, Location and Competitors
Table 42. Canon Medical Systems Brain Tumor Diagnosis and Treatments Major Business
Table 43. Canon Medical Systems Brain Tumor Diagnosis and Treatments Total Revenue (USD Million) (2017-2018)
Table 44. Canon Medical Systems SWOT Analysis
Table 45. Canon Medical Systems Brain Tumor Diagnosis and Treatments Product and Solutions
Table 46. Canon Medical Systems Brain Tumor Diagnosis and Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Philips Healthcare Corporate Information, Location and Competitors
Table 48. Philips Healthcare Brain Tumor Diagnosis and Treatments Major Business
Table 49. Philips Healthcare Brain Tumor Diagnosis and Treatments Total Revenue (USD Million) (2017-2018)
Table 50. Philips Healthcare SWOT Analysis
Table 51. Philips Healthcare Brain Tumor Diagnosis and Treatments Product and Solutions
Table 52. Philips Healthcare Brain Tumor Diagnosis and Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Merck Corporate Information, Location and Competitors
Table 54. Merck Brain Tumor Diagnosis and Treatments Major Business
Table 55. Merck Brain Tumor Diagnosis and Treatments Total Revenue (USD Million) (2017-2018)
Table 56. Merck SWOT Analysis
Table 57. Merck Brain Tumor Diagnosis and Treatments Product and Solutions
Table 58. Merck Brain Tumor Diagnosis and Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Siemens Healthineers Corporate Information, Location and Competitors
Table 60. Siemens Healthineers Brain Tumor Diagnosis and Treatments Major Business
Table 61. Siemens Healthineers Brain Tumor Diagnosis and Treatments Total Revenue (USD Million) (2017-2018)
Table 62. Siemens Healthineers SWOT Analysis
Table 63. Siemens Healthineers Brain Tumor Diagnosis and Treatments Product and Solutions
Table 64. Siemens Healthineers Brain Tumor Diagnosis and Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Brain Tumor Diagnosis and Treatments Revenue (Million USD) by Players (2015-2020)
Table 66. Global Brain Tumor Diagnosis and Treatments Revenue Share by Players (2015-2020)
Table 67. Global Brain Tumor Diagnosis and Treatments Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Brain Tumor Diagnosis and Treatments Revenue Market Share by Regions (2015-2020)
Table 69. North America Brain Tumor Diagnosis and Treatments Revenue by Countries (2015-2020)
Table 70. North America Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries (2015-2020)
Table 71. Europe Brain Tumor Diagnosis and Treatments Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Brain Tumor Diagnosis and Treatments Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Brain Tumor Diagnosis and Treatments Revenue by Countries (2015-2020)
Table 74. South America Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Brain Tumor Diagnosis and Treatments Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries (2015-2020)
Table 77. Global Brain Tumor Diagnosis and Treatments Revenue (Million USD) by Type (2015-2020)
Table 78. Global Brain Tumor Diagnosis and Treatments Revenue Share by Type (2015-2020)
Table 79. Global Brain Tumor Diagnosis and Treatments Revenue Forecast by Type (2021-2025)
Table 80. Global Brain Tumor Diagnosis and Treatments Revenue by Application (2015-2020)
Table 81. Global Brain Tumor Diagnosis and Treatments Revenue Share by Application (2015-2020)
Table 82. Global Brain Tumor Diagnosis and Treatments Revenue Forecast by Application (2021-2025)
Table 83. Global Brain Tumor Diagnosis and Treatments Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Brain Tumor Diagnosis and Treatments Picture
Figure 2. Global Brain Tumor Diagnosis and Treatments Revenue Market Share by Type in 2019
Figure 3. Primary Brain Tumor Picture
Figure 4. Secondary Brain Tumor Picture
Figure 5. Brain Tumor Diagnosis and Treatments Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Medical center Picture
Figure 8. Global Brain Tumor Diagnosis and Treatments Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Brain Tumor Diagnosis and Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Brain Tumor Diagnosis and Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Brain Tumor Diagnosis and Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Brain Tumor Diagnosis and Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Brain Tumor Diagnosis and Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Brain Tumor Diagnosis and Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Brain Tumor Diagnosis and Treatments Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Brain Tumor Diagnosis and Treatments Revenue Market Share in 2019
Figure 17. Global Top 10 Players Brain Tumor Diagnosis and Treatments Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Brain Tumor Diagnosis and Treatments Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Brain Tumor Diagnosis and Treatments Revenue Market Share by Regions (2015-2020)
Figure 21. Global Brain Tumor Diagnosis and Treatments Revenue Market Share by Regions in 2018
Figure 22. North America Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 23. Europe Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 25. South America Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 27. North America Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries (2015-2020)
Figure 28. North America Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries in 2019
Figure 29. USA Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 30. Canada Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 32. Europe Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries in 2019
Figure 34. Germany Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 35. UK Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 36. France Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 37. Russia Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 38. Italy Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries in 2019
Figure 41. China Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 42. Japan Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 43. Korea Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 44. India Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 46. South America Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries (2015-2020)
Figure 47. South America Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries in 2019
Figure 48. Brazil Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Brain Tumor Diagnosis and Treatments Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 53. UAE Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Brain Tumor Diagnosis and Treatments Revenue and Growth Rate (2015-2020)
Figure 56. Global Brain Tumor Diagnosis and Treatments Revenue Share by Type (2015-2020)
Figure 57. Global Brain Tumor Diagnosis and Treatments Revenue Share by Type in 2019
Figure 58. Global Brain Tumor Diagnosis and Treatments Market Share Forecast by Type (2021-2025)
Figure 59. Global Primary Brain Tumor Revenue Growth Rate (2015-2020)
Figure 60. Global Secondary Brain Tumor Revenue Growth Rate (2015-2020)
Figure 61. Global Brain Tumor Diagnosis and Treatments Revenue Share by Application (2015-2020)
Figure 62. Global Brain Tumor Diagnosis and Treatments Revenue Share by Application in 2019
Figure 63. Global Brain Tumor Diagnosis and Treatments Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospital Revenue Growth Rate (2015-2020)
Figure 65. Global Medical center Revenue Growth Rate (2015-2020)
Figure 66. Global Brain Tumor Diagnosis and Treatments Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Brain Tumor Diagnosis and Treatments Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Brain Tumor Diagnosis and Treatments Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Brain Tumor Diagnosis and Treatments Revenue Market Forecast (2021-2025)
Figure 70. Europe Brain Tumor Diagnosis and Treatments Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Brain Tumor Diagnosis and Treatments Revenue Market Forecast (2021-2025)
Figure 72. South America Brain Tumor Diagnosis and Treatments Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Brain Tumor Diagnosis and Treatments Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
脳腫瘍診断・治療の世界市場（～2026年） With the increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical exposure, the demand of Diagnosis and treatment of brain tumors is increasing. Market Analysis and Insights: Global Brain Tumor Diagnosis and Treatments Market The global Brain Tumo…- 小児脳腫瘍の世界市場（～2026年） Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant). Treatment and chance of recovery (prog…
- 脳腫瘍治療薬の世界市場（～2026年） A brain tumor occurs when abnormal cells form within the brain. North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics mark…
- 脳腫瘍治療の世界市場（～2026年） Treatment for brain tumors depends on a number of factors including the type, location and size of the tumor as well as the patient's age and general health. Various treatments for curing brain tumor are surgery, radiation therapy, and chemotherapy, immunotherapy and so on which reduce the symptoms …
- 腫瘍治療フィールド（TTField）の世界市場（～2026年） Tumor Treating Field (TTField) is an anticancer treatment which disrupts the tumor cells mitosis. Tumor Treating Field is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. North America is projected to hold larges…